High levels of GSTZ1 expression conferred resistance to the effect of anti-cancer therapy of dichloroacetate in hepatocellular carcinoma cell lines by an independent mechanism to tyrosine metabolism [49, 50]. Here, GSTZ1 is linked to hepatocellular carcinoma.